KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Operating Expenses: 2009-2014

Historic Operating Expenses for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $59.4 million.

  • Biocryst Pharmaceuticals' Operating Expenses rose 62.64% to $24.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $86.5 million, marking a year-over-year increase of 55.37%. This contributed to the annual value of $59.4 million for FY2014, which is 23.58% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Operating Expenses of $59.4 million as of FY2014, which was up 23.58% from $48.0 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Operating Expenses ranged from a high of $96.7 million in FY2010 and a low of $48.0 million during FY2013.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Operating Expenses value was $59.4 million (recorded in 2014), while the average stood at $55.9 million.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Operating Expenses decreased by 28.44% in 2011, and later grew by 23.58% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Operating Expenses (Yearly) stood at $96.7 million in 2010, then fell by 28.44% to $69.2 million in 2011, then declined by 13.07% to $60.2 million in 2012, then decreased by 20.16% to $48.0 million in 2013, then grew by 23.58% to $59.4 million in 2014.